One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
**Objectives:** Little is known about severe chronic obstructive pulmonary disease (COPD) exacerbations among patients with Alpha-1 Antitrypsin Deficiency (AATD). We assessed inpatients with AATD and COPD among a sample of COPD inpatients to ascertain demographic, clinical and economic differences i...
Saved in:
Main Authors: | Christopher M. Blanchette, Emily Zacherle, Joshua M. Noone, Bryce A. Van Doren, Debosree Roy, Reuben Howden |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2017-07-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9799 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01) -
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency
by: A. Vianello, et al.
Published: (2025-01-01) -
Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports
by: Gordon M, et al.
Published: (2025-01-01) -
Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency
by: Ho-Man Yeung, et al.
Published: (2022-01-01) -
Pulmonary artery aneurysm as a rare manifestation of Alpha-1 antitrypsin deficiency
by: Mark A. Colantonio, et al.
Published: (2025-01-01)